Jason McLellan’s groundbreaking research is changing the way vaccines are developed—including those for another formidable pathogen, RSV.
Taxpayers have spent millions for purifiers promoted by former governor Rick Perry. Could they have gotten the same benefits for far less money?
A highly unusual summer outbreak of RSV and an increase in COVID-19 cases among kids have overrun hospitals.
For low-income countries, the less-expensive, easier-to-make Corbevax could prove a godsend.
Houston-based Luminare’s software analyzes patient records to detect sepsis.
As vaccination rates slow, a Dallas woman who once garnered hundreds of thousands of social followers by expressing doubt about the safety of inoculations now says, “I trust the science.”
Last month’s winter storm decimated the state’s populations of the winged mammals, which may have lasting ecological effects.
Graduate student Ambalika Tanak’s biomedical sensor carries the promise of helping doctors fight a silent killer.
